Literature DB >> 10499826

Fas/Fas ligand on the road: an apoptotic pathway common to AIDS, autoimmunity, lymphoproliferation and transplantation.

G Famularo1, E Nucera, S Marcellini, C De Simone.   

Abstract

There is considerable interest in the role of Fas protein as it induces apoptotic cell death when ligated by its natural ligand (FasL). Interaction between Fas and FasL is a crucial mechanism for clonal deletion and immune tolerance and privilege, control of T cell expansion during immune responses and killing by cytotoxic T lymphocytes. Loss of function of the system can block lymphocyte apoptosis and cause lymphoproliferation and autoimmunity but, when the system overfunctions, it can end to tissue injury and destruction. Recent studies have demonstrated that the Fas/FasL system is implicated in the pathogenesis of several human diseases ranging from AIDS to autoimmunity and lymphoproliferation, hepatitis, multiple sclerosis and transplant rejection. It is conceivable that modulating the activity of the Fas/fasL pathway would have clinical applications for the treatment of these patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10499826     DOI: 10.1054/mehy.1997.0712

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

1.  Inhibition of mitochondrial respiration by endogenous nitric oxide: a critical step in Fas signaling.

Authors:  Belén Beltrán; Marisol Quintero; Eugenia García-Zaragozá; Enrique O'Connor; Juan V Esplugues; Salvador Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

2.  Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.

Authors:  M N Lub-de Hooge; E G E de Vries; S de Jong; M Bijl
Journal:  Ann Rheum Dis       Date:  2004-11-25       Impact factor: 19.103

3.  Fas-disabling small exocyclic peptide mimetics limit apoptosis by an unexpected mechanism.

Authors:  Akihiro Hasegawa; Xin Cheng; Kiichi Kajino; Alan Berezov; Kaoru Murata; Toshinori Nakayama; Hideo Yagita; Ramachandran Murali; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-14       Impact factor: 11.205

4.  Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death.

Authors:  Min Li-Weber; Markus A Weigand; Marco Giaisi; Dorothee Süss; Monika K Treiber; Sven Baumann; Elena Ritsou; Raoul Breitkreutz; Peter H Krammer
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 5.  Autoimmunity in immunodeficiency.

Authors:  Krista Todoric; Jessica B Koontz; Daniel Mattox; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.